Categories Analysis, Finance, U.S. Markets News

2019 might be good for derivatives after a record-breaking 2018 for CME Group

Derivatives marketplace CME Group (CME) on Thursday posted an 18% hike in 2018 average daily volume as it hit a record 19.2 million contracts. In 2018, CME Group saw 91 trading days exceed 20 million contracts, 34 days more than in 2017.

Interest rate average daily volume (ADV) for 2018 soared 22% to 9.95 million contracts, while metals ADV jumped 12% to 638,000 contracts. FX ADV rose 9% to a million contracts.

Options ADV for 2018 saw a record 3.9 million contracts, up 14%. This included electronic options ADV rising 20% to 2.6 million contracts.

In the fourth quarter of 2018, the average volume soared 31% to 20.8 million contracts per day.

December 2018 volume averaged 20.2 contracts per day, up 36%. Electronic options ADV grew 39% to 2.7 million contracts in the month, while interest rate options ADV jumped 40% to 2.4 million contracts. Equity Index options ADV soared 48% to 974,000 contracts, while agricultural options ADV inched 2% to 169,000 contracts. Metals options ADV rose 28% to 59,000 contracts.

Foreign exchange volume averaged a million contracts per day in December 2018, with Canadian dollar futures and options ADV rising 10% to 105,000 contracts, and Japanese yen futures and options inching 7% up to 177,000 contracts.

However, energy volume fell 2% as it averaged 2.3 million contracts per day in December 2018. Even though WTI Crude Oil futures and options ADV jumped 18% to 1.5 million contracts, Gasoline futures and options ADV trailed — inching just 1% higher to 174,000 contracts.

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top